Cargando…

Addition of cranberry to proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

OBJECTIVE: Proton pump inhibitor-based triple therapy with two antibiotics for Helicobacter pylori eradication is widely accepted, but this combination fails in a considerable number of cases. Some studies have shown that cranberry inhibits the adhesion of a wide range of microbial pathogens, includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyyedmajidi, Mohammadreza, Ahmadi, Anahita, Hajiebrahimi, Shahin, Seyedmajidi, Seyedali, Rajabikashani, Majid, Firoozabadi, Mona, Vafaeimanesh, Jamshid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084481/ https://www.ncbi.nlm.nih.gov/pubmed/27843960 http://dx.doi.org/10.4103/2279-042X.192462

Ejemplares similares

Levofloxacin-containing triple therapy versus bismuth-based quadruple therapy as regimens for second line anti- Helicobacter pylori
por: Seyyedmajidi, Mohamadreza, et al.
Publicado: (2019)

Comparison of Helicobacter pylori eradication regimens in patients with end stage renal disease
por: Seyyed Majidi, Mohammadreza, et al.
Publicado: (2018)

Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Preoperative esophagogastroduodenoscopy findings and effects on laparoscopic Roux-en-Y gastric bypass in area with high prevalence of Helicobacter pylori infection: multi-center experience in Iran
por: Alimadadi, Mehdi, et al.
Publicado: (2022)

Helicobacter pylori Infection and Insulin Resistance in Diabetic and Nondiabetic Population
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Hem-o-Lok Clip in the First Part of Duodenum after Laparoscopic Cholecystectomy
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2013)

Association of Helicobacter pylori Infection with Coronary Artery Disease: Is Helicobacter pylori a Risk Factor?
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Comparing the Effect of Two Low-dose and High-dose Four-drug Regimens of Furazolidone in Eradicating Helicobacter Pylori
por: Seyedmajidi, Mohammad Reza, et al.
Publicado: (2021)

Comparison of Azithromycin and Clarithromycin Triple Therapy Regimens for Helicobacter Pylori Eradication in Hemodialysis Patients
por: Jalalzadeh, Mojgan, et al.
Publicado: (2012)

Risk factors, endoscopic findings, and treatments in upper gastrointestinal bezoars: multi-center experience in Iran
por: Hemmasi, Gholamreza, et al.
Publicado: (2021)

An Interesting Finding in Upper Gastrointestinal Endoscopy
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2020)

Helicobacter pylori eradication in the management of glaucoma
por: Ala, Shahram, et al.
Publicado: (2020)

Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics?
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2015)

Effect of Helicobacter pylori Infection on Serum Lipid Profile
por: Haeri, Mohamadreza, et al.
Publicado: (2018)

Subclavian artery-esophageal fistula after placement of a self-expanding metal stent in a patient with esophagogastric anastomosis stenosis
por: Seyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Relationship between Helicobacter pylori and idiopathic chronic urticaria: effectiveness of Helicobacter pylori eradication
por: Mogaddam, Majid Rostami, et al.
Publicado: (2015)

Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy
por: Sakurai, Kouichi, et al.
Publicado: (2017)

Serum Adiponectin Level in Diabetic Patients with and without Helicobacter pylori Infection: Is There Any Difference?
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Effect of Helicobacter pylori on metabolic syndrome parameters in diabetic patients
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2016)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Diabetic patients infected with helicobacter pylori have a higher Insulin Resistance Degree
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Newer agents for Helicobacter pylori eradication
por: Fiorini, Giulia, et al.
Publicado: (2012)

Recent advances in Helicobacter pylori eradication
por: Niv, Yaron, et al.
Publicado: (2015)

Efficacy of Vonoprazan for Helicobacter pylori Eradication
por: Kiyotoki, Shu, et al.
Publicado: (2019)

Vonoprazan on the Eradication of Helicobacter pylori Infection
por: Huang, Jiaming, et al.
Publicado: (2023)

Does Helicobacter pylori eradication or proton pump inhibitor use benefit gastroesophageal reflux disease?
por: Sakin, Yusuf Serdar, et al.
Publicado: (2015)

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Tanabe, Hiroki, et al.
Publicado: (2018)

Efficacy of Two Triple Eradication Regimens in Children with Helicobacter pylori Infection
por: Choi, Jungi, et al.
Publicado: (2006)

Update on triple therapy for eradication of Helicobacter pylori: current status of the art
por: Urgesi, Riccardo, et al.
Publicado: (2012)

Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori
por: Mokhtare, Marjan, et al.
Publicado: (2015)

Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication
por: Kusunoki, Maho, et al.
Publicado: (2019)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
por: Zhang, Zinan, et al.
Publicado: (2023)

Efficacy of Proton Pump Inhibitor-based Triple Therapy and Bismuth-based Quadruple Therapy for Helicobacter pylori Eradication in Korean Children
por: Hong, Jeana, et al.
Publicado: (2012)

The cost-effectiveness of sequential versus standard triple therapy for Helicobacter pylori eradication in Saudi Arabia
por: AlRuthia, Yazed, et al.
Publicado: (2021)

Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
por: Cheung, Ka Shing, et al.
Publicado: (2018)

Lifestyle‐ and comorbidity‐related factors for the prescription of proton pump inhibitors after Helicobacter pylori eradication in Japan
por: Shimada, Furitsu, et al.
Publicado: (2021)

Helicobacter pylori Eradication Therapy: Current Availabilities
por: Gasparetto, M., et al.
Publicado: (2012)

Effect of Helicobacter pylori Eradication on Functional Dyspepsia
por: Kim, Sung Eun, et al.
Publicado: (2013)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Hybrid Therapy Regimen for Helicobacter Pylori Eradication
por: Song, Zhi-Qiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_k42sqmr3b3d7hn0op6rd7ik8a6